RYBREVANT FASPRO™ Receives FDA Approval for First-Line EGFR-Mutated NSCLC
December 26, 2025
Brand Name :
N/A
Synonyms :
rolusafine
Class :
Antifungal agent
Dosage forms and strengths
The drug is investigational and is studied for the treatment of fungal infections
Not indicated
Refer adult dosing
Actions and Spectrum:
Action:
Rolusafine is mainly used for research.
Drug investigations are carried out to treat fungal infections.
Frequency not defined
None
Black Box Warning:
None
Contraindication/Caution:
Limited information available
Pregnancy warnings:
Pregnancy category: N/A
Lactation: Excreted into human milk is unknown
Pregnancy Categories:
Category A: Studies that were well-controlled and met expectations revealed no risk to the fetus in either the first or second trimester.
<b>Category B: There were a lack of studies on pregnant women and no evidence of risk to the fetus in animal experiments.
Category C: There was evidence of risk of adverse effects in animal reproduction studies, and no adequate evidence in human studies must take care of potential risks in pregnant women.
Category D: Adequate data with sufficient evidence of human fetal risk from various platforms, but despite the potential risk, and used only in emergency cases for potential benefits.
Category X: Drugs listed in this category outweigh the risks over benefits. Hence these categories of drugs need to be avoided by pregnant women.
Category N: There is no data available for the drug under this category
Pharmacology:
Pharmacodynamics:
Rolusafine is mainly used for research.
Drug investigations are carried out to treat fungal infections.
Pharmacokinetics:
Limited information available
Administration:
Limited information available
Patient information leaflet
Generic Name: rolusafine
Why do we use rolusafine?
Rolusafine is mainly used for research.
Drug investigations are carried out to treat fungal infections.